CSF2 and neuroblastoma: A recent study has shown that GM-CSF (20 ng/ml) in combination with either CpG- or non-CpG-ODN was capable of inducing several chemokines in primary human monocytes [72], as well as in lymphoma and neuroblastoma models [73,74].